Environmental variations in endophthalmitis
3 August 2023
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Endophthalmitis, anti-VEGF, climate, intravitreal injection, season
In this retrospective cohort study, the authors looked at seasonal and environmental variations in 171 endophthalmitis cases out of 423,297 intravitreal injections. The incidence of this complication was not correlated to monthly snowfall, rainfall, or average temperature. There was no...
Effect of syringe-filling technique and risk for endophthalmitis after intravitreal injection of anti-VEGF agents
2 August 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Aflibercept, Anti-vascular endothelial growth factor, Bevacizumab, Endophthalmitis, Filling, Prefilled syringe, Ranibizumab, Syringe
In this retrospective study the authors compare the risk for post-injection endophthalmitis between different anti-vascular endothelial growth factor (VEGF) agents and syringe preparation technique. This multicentre study included 197,402 injections. The drugs included in this study were three Anti-VEGF agents...
Risk factors and prognosis of paediatric open globe injuries
1 October 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Choroidal damage, Endophthalmitis, No light perception, Pediatric open globe injuries, Vitreoretinal surgery
This retrospective, comparative, interventional case-control study was aimed to investigate possible risk factors and prognosis of initial no light perception (NLP) in paediatric open globe injuries (POGI). A total of 851 cases were reviewed, including 837 unilateral cases and 14...
